Divis Laboratories Sees Robust Call Option Activity Amid Bullish Market Sentiment

Strong Call Option Interest at Key Strike Prices

Recent data reveals that Divis Laboratories has witnessed substantial call option activity for contracts expiring on 30 December 2025. The most actively traded call options are concentrated at strike prices of ₹6,500 and ₹6,600, both slightly below and above the current underlying stock price of ₹6,582. This clustering suggests that traders are positioning for potential upward movement in the stock price by the end of the month.

At the ₹6,500 strike, 7,130 contracts were traded, generating a turnover of approximately ₹1010.89 lakhs, with an open interest of 1,278 contracts. Meanwhile, the ₹6,600 strike saw even higher activity, with 12,084 contracts traded and a turnover of ₹1,177.34 lakhs, alongside an open interest of 2,486 contracts. The elevated open interest at these strikes indicates sustained interest and commitment from market participants, reflecting expectations of the stock maintaining or surpassing these levels.

Underlying Stock Performance Supports Bullish Sentiment

Divis Laboratories has demonstrated notable performance in the cash market, which complements the observed derivatives activity. The stock outperformed its Pharmaceuticals & Biotechnology sector by 1.86% on the day, registering a 3.21% return compared to the sector’s 1.13% and the Sensex’s 0.57%. Over the last two consecutive trading sessions, the stock has delivered a cumulative return of 4.42%, underscoring positive momentum.

Intraday, Divis Laboratories touched a high of ₹6,598, representing a 3.42% rise from previous levels. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which often signals sustained strength and investor confidence in the medium to long term.

Rising Investor Participation and Liquidity

Investor engagement in Divis Laboratories has shown a marked increase, with delivery volumes on 18 December reaching 2.76 lakh shares. This figure is 153.89% higher than the five-day average delivery volume, indicating heightened interest from long-term investors and traders alike. Such a surge in delivery volume often reflects conviction in the stock’s prospects beyond short-term speculation.

Liquidity metrics also support active trading, with the stock’s traded value comfortably accommodating trade sizes of up to ₹2.67 crore based on 2% of the five-day average traded value. This level of liquidity is favourable for institutional and retail investors seeking to enter or exit positions without significant price impact.

Market Capitalisation and Sector Context

Divis Laboratories holds a market capitalisation of approximately ₹1,69,589 crore, categorising it as a large-cap stock within the Pharmaceuticals & Biotechnology sector. This stature often attracts institutional investors and funds seeking stable exposure to the healthcare space, which is known for its defensive qualities and growth potential.

The sector itself has been under focus due to ongoing developments in biotechnology and pharmaceutical innovation, as well as global health trends. Divis Laboratories’ performance relative to its sector peers and the broader market indices suggests it remains a key player with considerable investor interest.

Expiry Patterns and Option Market Dynamics

The December 2025 expiry date for the active call options is approaching, which typically leads to increased trading volumes and open interest as traders adjust their positions. The concentration of activity at the ₹6,500 and ₹6,600 strikes indicates that market participants are closely monitoring these levels as potential price targets or support zones.

Open interest figures provide insight into the strength of these positions. The higher open interest at the ₹6,600 strike compared to ₹6,500 suggests a greater number of contracts remain outstanding at this level, possibly reflecting expectations of the stock moving beyond ₹6,600 by expiry. This scenario aligns with the stock’s recent upward trajectory and technical indicators.

Implications for Investors and Traders

For investors, the combination of strong call option activity, rising delivery volumes, and the stock’s position above key moving averages may indicate a positive market assessment of Divis Laboratories’ near-term prospects. Traders might interpret the option market data as a signal of bullish sentiment, potentially influencing their strategies around the December expiry.

However, as with all derivatives trading, it is important to consider the inherent risks and the possibility of volatility as expiry approaches. The stock’s performance relative to sector and benchmark indices should be monitored closely alongside broader market conditions.

Conclusion: A Watchful Eye on Divis Laboratories’ Derivatives Activity

Divis Laboratories’ active call option trading at strike prices near the current market value, combined with its recent price performance and increased investor participation, highlights a market environment that favours bullish expectations. The stock’s liquidity and large-cap status further support its appeal among diverse investor groups.

As the December expiry approaches, market participants will be closely observing price movements and option market dynamics to gauge the sustainability of this momentum. Investors and traders alike should consider these factors alongside broader sector trends and global market conditions when evaluating Divis Laboratories’ outlook.

Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Start Saving Now →